| RVFV | Rift Valley Fever Virus |
| WHO | World Health Organization |
| DC-SIGN | Dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin |
| L-SIGN | Liver/lymph node-specific intercellular adhesion molecule-3-grabbing non-integrin |
| LRP1 | Low-density lipoprotein receptor-related protein 1 |
| BBB | Blood–brain barrier |
| hBLEC | Human Brain-like endothelial cells |
| CNS | Central nervous system |
| NSs | Nonstructural protein encoded by the RVFV S segment |
| MAVS | Mitochondrial antiviral-signaling protein |
| CCR5 | C–C chemokine receptor type 5 |
| RNA | Ribonucleic acid |
| HIV | Human immunodeficiency virus |
| SARS-CoV-2 | Severe acute respiratory syndrome coronavirus 2 |
| HBV | Hepatitis B virus |
| HDV | Hepatitis D virus |
| TLR2 | Toll-like receptor 2 |
| TLR7 | Toll-like receptor 7 |
| shRNA | Short hairpin RNA |
| siRNA | Small interfering RNA |
| RNP | Ribonucleoprotein |
| STAT1 | Signal transducer and activator of transcription |
| PK/PD | pharmacokinetics/pharmacodynamics |